The galactosylation of N(ω)-nitro-L-arginine enhances its anti-nocifensive or anti-allodynic effects by targeting glia in healthy and neuropathic mice.

[1]  H. Dickel,et al.  Standardized tape stripping prior to patch testing induces upregulation of Hsp90, Hsp70, IL‐33, TNF‐α and IL‐8/CXCL8 mRNA: new insights into the involvement of ‘alarmins’ , 2010, Contact dermatitis.

[2]  M. Frassanito,et al.  Regulation of mRNA caspase-8 levels by anti-nuclear autoantibodies , 2010, Clinical and Experimental Medicine.

[3]  K. Chow,et al.  Microarray detection of gene overexpression in primary spontaneous pneumothorax , 2010, Experimental lung research.

[4]  S. Dupré-Aucouturier,et al.  Oxidative stress, apoptosis, and proteolysis in skeletal muscle repair after unloading. , 2010, American journal of physiology. Cell physiology.

[5]  M. G. Rimoli,et al.  Galactosyl derivative of Nω‐nitro‐L‐arginine: Study of antiproliferative activity on human thyroid follicular carcinoma cells , 2009, Journal of cellular physiology.

[6]  H. Pan,et al.  Plasticity and emerging role of BKCa channels in nociceptive control in neuropathic pain , 2009, Journal of neurochemistry.

[7]  K. Ishige,et al.  Apolipoprotein E-deficient mice are more vulnerable to ER stress after transient forebrain ischemia , 2009, Neurochemistry International.

[8]  Jianjun Yang,et al.  Effects of recombinant human erythropoietin on neuropathic pain and cerebral expressions of cytokines and nuclear factor-kappa B , 2009, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[9]  K. Ishige,et al.  Characterization of chronic glutamate-mediated motor neuron toxicity in organotypic spinal cord culture prepared from ALS model mice , 2009, Neuroscience Letters.

[10]  Y. Li,et al.  Endoplasmic reticulum in the penumbra following middle cerebral artery occlusion in the rabbit , 2009, Neurological Sciences.

[11]  Vasco Galhardo,et al.  Forebrain pain mechanisms , 2009, Brain Research Reviews.

[12]  S. Fan,et al.  Stronger expression of CHOP and caspase 12 in diabetic spinal cord injury rats , 2009, Neurological research.

[13]  D. Siniscalco,et al.  A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice. , 2009, European journal of pharmacology.

[14]  Daniel R. Caffrey,et al.  AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC , 2009, Nature.

[15]  J. Alferink,et al.  Interferon-γ Is a Critical Modulator of CB2 Cannabinoid Receptor Signaling during Neuropathic Pain , 2008, The Journal of Neuroscience.

[16]  W. Guo,et al.  Supraspinal Glial–Neuronal Interactions Contribute to Descending Pain Facilitation , 2008, The Journal of Neuroscience.

[17]  R. Dubner,et al.  Neuron-glia crosstalk gets serious: role in pain hypersensitivity. , 2008, Current opinion in anaesthesiology.

[18]  G. Geisslinger,et al.  The IKK‐NF‐κB pathway: a source for novel molecular drug targets in pain therapy? , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  S. Kuo,et al.  Inhibition of nitric oxide production by the carbazole compound LCY-2-CHO via blockade of activator protein-1 and CCAAT/enhancer-binding protein activation in microglia. , 2008, Biochemical pharmacology.

[20]  E. Romero-Sandoval,et al.  Neuroimmune interactions and pain: focus on glial-modulating targets. , 2008, Current opinion in investigational drugs.

[21]  L. Rodella,et al.  The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1β, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice , 2008, PAIN®.

[22]  M. Malcangio,et al.  Spinal changes associated with mechanical hypersensitivity in a model of Guillain–Barré syndrome , 2008, Neuroscience Letters.

[23]  Ji Zhang,et al.  Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain , 2008, PAIN®.

[24]  D. Siniscalco,et al.  Involvement of subtype 1 metabotropic glutamate receptors in apoptosis and caspase-7 over-expression in spinal cord of neuropathic rats. , 2008, Pharmacological research.

[25]  S. Maier,et al.  “Listening” and “talking” to neurons: Implications of immune activation for pain control and increasing the efficacy of opioids , 2007, Brain Research Reviews.

[26]  C. Woolf,et al.  The neuropathic pain triad: neurons, immune cells and glia , 2007, Nature Neuroscience.

[27]  S. Bevan,et al.  Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.

[28]  Eva Mezey,et al.  Simultaneous Visualization of Multiple Antigens with Tyramide Signal Amplification using Antibodies from the same Species , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[29]  C. Svensson,et al.  Inhibition of spinal constitutive NOS‐2 by 1400W attenuates tissue injury and inflammation‐induced hyperalgesia and spinal p38 activation , 2007, The European journal of neuroscience.

[30]  M. Costigan,et al.  Spinal microglia and neuropathic pain in young rats , 2007, PAIN.

[31]  Hun-Kuk Park,et al.  Amygdalin suppresses lipopolysaccharide-induced expressions of cyclooxygenase-2 and inducible nitric oxide synthase in mouse BV2 microglial cells , 2007, Neurological research.

[32]  D. Siniscalco,et al.  Role of reactive oxygen species and spinal cord apoptotic genes in the development of neuropathic pain. , 2007, Pharmacological research.

[33]  J. Eisenach,et al.  Neuronal nitric oxide synthase is upregulated in a subset of primary sensory afferents after nerve injury which are necessary for analgesia from α2-adrenoceptor stimulation , 2007, Brain Research.

[34]  S. Raja,et al.  Genetic knockout and pharmacologic inhibition of neuronal nitric oxide synthase attenuate nerve injury-induced mechanical hypersensitivity in mice , 2007, Molecular pain.

[35]  R. Ambron,et al.  Activation and retrograde transport of protein kinase G in rat nociceptive neurons after nerve injury and inflammation , 2006, Neuroscience.

[36]  C. Giaume,et al.  Glucose metabolism and proliferation in glia: role of astrocytic gap junctions , 2006, Journal of neurochemistry.

[37]  M. G. Rimoli,et al.  Galactosyl derivatives of L-arginine and D-arginine: synthesis, stability, cell permeation, and nitric oxide production in pituitary GH3 cells. , 2006, Journal of medicinal chemistry.

[38]  S. Murray,et al.  Spinal distribution and metabolism of 2′-O-(2-methoxyethyl)-modified oligonucleotides after intrathecal administration in rats , 2005, Neuroscience.

[39]  R. Johns,et al.  Effect of genetic knockout or pharmacologic inhibition of neuronal nitric oxide synthase on complete Freund's adjuvant-induced persistent pain , 2005, Pain.

[40]  D. Lodge,et al.  Experiments with nitric oxide synthase inhibitors in spinal nerve ligated rats provide no evidence of a role for nitric oxide in neuropathic mechanical allodynia , 2005, Neuroscience Letters.

[41]  S. Maier,et al.  Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation , 2005, Pain.

[42]  D. Siniscalco,et al.  Neuropathic pain: is the end of suffering starting in the gene therapy? , 2005, Current drug targets.

[43]  J. Levine,et al.  Caspase signalling in neuropathic and inflammatory pain in the rat , 2004, The European journal of neuroscience.

[44]  P. Vandenabeele,et al.  Caspase-1 Activates Nuclear Factor of the κ-Enhancer in B Cells Independently of Its Enzymatic Activity* , 2004, Journal of Biological Chemistry.

[45]  L. Santoro,et al.  Blockade of glutamate mGlu5 receptors in a rat model of neuropathic pain prevents early over-expression of pro-apoptotic genes and morphological changes in dorsal horn lamina II , 2004, Neuropharmacology.

[46]  E. Newman.  New roles for astrocytes: Regulation of synaptic transmission , 2003, Trends in Neurosciences.

[47]  A. Takeshita,et al.  Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats , 2003, Journal of hypertension.

[48]  M. G. Rimoli,et al.  Glycosyl Derivatives of Dopamine and l-dopa as Anti-Parkinson Prodrugs: Synthesis, Pharmacological Activity and In Vitro Stability Studies , 2003, Journal of drug targeting.

[49]  R. Fields,et al.  New insights into neuron-glia communication. , 2002, Science.

[50]  J. Mars̆ala,et al.  Neuropathic pain is associated with alterations of nitric oxide synthase immunoreactivity and catalytic activity in dorsal root ganglia and spinal dorsal horn , 2002, Brain Research Bulletin.

[51]  C. Janeway,et al.  RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems , 2002, Nature.

[52]  L. Hersh,et al.  Neutral endopeptidase knockout induces hyperalgesia in a model of visceral pain, an effect related to bradykinin and nitric oxide , 2002, Journal of Molecular Neuroscience.

[53]  D. Siniscalco,et al.  Apoptotic genes expression in the lumbar dorsal horn in a model neuropathic pain in rat , 2002, NeuroReport.

[54]  D Le Bars,et al.  Animal models of nociception. , 2001, Pharmacological reviews.

[55]  Á. Almeida,et al.  Expression of glucose transporter GLUT3 by endotoxin in cultured rat astrocytes: the role of nitric oxide , 2001, Journal of neurochemistry.

[56]  Z. Khalil,et al.  A role for free radicals and nitric oxide in delayed recovery in aged rats with chronic constriction nerve injury. , 2001, Free radical biology & medicine.

[57]  H. Prast,et al.  Nitric oxide as modulator of neuronal function , 2001, Progress in Neurobiology.

[58]  H. Iwata,et al.  Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury. , 2000, Brain research. Molecular brain research.

[59]  C. Woolf,et al.  Spared nerve injury: an animal model of persistent peripheral neuropathic pain , 2000, Pain.

[60]  B. Tunctan,et al.  Participation of the components of L-arginine/nitric oxide/cGMP cascade by chemically-induced abdominal constriction in the mouse. , 2000, Life sciences.

[61]  Ronald J. Tallarida,et al.  Drug Synergism and Dose-Effect Data Analysis , 2000 .

[62]  R. Tallarida.  Dose-Response Analysis , 2000 .

[63]  W. Maixner,et al.  Microglial reactions after subcutaneous formalin injection into the rat hind paw , 1999, Brain Research.

[64]  U. Galderisi,et al.  Differentiation and apoptosis of neuroblastoma cells: Role of N‐myc gene product , 1999, Journal of cellular biochemistry.

[65]  H. Bruining,et al.  Distribution and metabolism of N G-nitro-l-arginine methyl ester in patients with septic shock , 1998, European Journal of Clinical Pharmacology.

[66]  D. Coyle,et al.  Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior , 1998, Glia.

[67]  B. Sung,et al.  Nitric oxide mediates behavioral signs of neuropathic pain in an experimental rat model , 1998, Neuroreport.

[68]  W. Willis,et al.  Changes in nitric oxide synthase isoforms in the spinal cord of rat following induction of chronic arthritis , 1998, Experimental Brain Research.

[69]  Xiao-jun Xu,et al.  Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered nitric oxide synthase inhibitors , 1996, PAIN®.

[70]  S. Raja,et al.  Neuropathic pain in rats is associated with altered nitric oxide synthase activity in neural tissue , 1996, Journal of the Neurological Sciences.

[71]  P. Greengard,et al.  cGMP-Dependent Protein Kinase in Dorsal Root Ganglion: Relationship with Nitric Oxide Synthase and Nociceptive Neurons , 1996, The Journal of Neuroscience.

[72]  T. Yamamoto,et al.  Role of Nitric Oxide in the Development of Thermal Hyperesthesia Induced by Sciatic Nerve Constriction Injury in the Rat , 1995, Anesthesiology.

[73]  R. Kamen,et al.  Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock , 1995, Cell.

[74]  M. Millan.  Serotonin and pain: evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice , 1994, Pain.

[75]  S. Baldwin,et al.  Mammalian passive glucose transporters: members of an ubiquitous family of active and passive transport proteins. , 1993, Biochimica et biophysica acta.

[76]  G. Gebhart,et al.  Nitric oxide (NO) and nociceptive processing in the spinal cord , 1993, Pain.

[77]  G. Gebhart,et al.  Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat , 1992, Neuroscience.

[78]  S H Snyder,et al.  Nitric oxide: first in a new class of neurotransmitters. , 1992, Science.

[79]  Richard Graham Knowles,et al.  Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[80]  L. Watkins,et al.  Pathological and protective roles of glia in chronic pain , 2009, Nature Reviews Neuroscience.

[81]  T. Lim,et al.  Compensatory caspase activation in MPP+-induced cell death in dopaminergic neurons , 2004, Cellular and Molecular Life Sciences CMLS.

[82]  S. Ferreira,et al.  Research Paper Mediators of Inflammation, 9, 25–30 (2000) , 2022 .